Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/703   
Active ingredient: Brivudine
Indication: Treatment of pancreatic cancer
Sponsor: RESprotect GmbH
Fiedlerstraße 34, D-01307 Dresden, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Orphan designation EMEA/OD/105/09 (2010)661 of 28/01/2010